Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of ... PipelineReview.com (press release) ROTTERDAM, The Netherlands & CAMBRIDGE, MA, USA I July 24, 2013 I Harbour Antibodies BV, the creator of transgenic mice to aid in the discovery of new human antibody-based therapies, has raised €2.5M ($3.3M) to continue R&D and commercialize ... |